GlassScriptPhysician profile
Holly Deann Bracy
NPI 1205140480
$1,039.21
in general payments reported to CMS, 2019-2025
19 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.13 · 2020: $49.21 · 2021: $139 · 2022: $248 · 2023: $152 · 2024: $260 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $169.44 | 2023-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $123.87 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $122.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.80 | 2020-2024 | |
| Daiichi Sankyo INC. | $94.31 | 2021-2023 | Injectafer |
| Mayne Pharma Commercial LLC | $82.38 | 2023-2025 | |
| Sage Therapeutics, LLC | $64.95 | 2023-2024 | |
| Pfizer INC. | $52.33 | 2022-2024 | |
| Coopersurgical, INC. | $41.58 | 2021 | |
| Abbvie INC. | $37.75 | 2021 | |
| Boston Scientific Corporation | $26.46 | 2025 | Wavewriter Alpha Prime 16 |
| Hologic Sales and Service, LLC | $21.83 | 2025 | Aptima |
| Vertex Pharmaceuticals Incorporated | $19.30 | 2025 | |
| Shield Therapeutics INC | $16.24 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $15.24 | 2025 | Iovera, Zilretta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $14.88 | 2024 | Ova1 |
| Amag Pharmaceuticals, INC. | $14.13 | 2019 | |
| Merck Sharp & Dohme LLC | $13.94 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Bracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.